Use of IFNγ/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic Shock
Large clinical trials testing hydrocortisone therapy in septic shock have produced conflicting results. Subgroups may benefit of hydrocortisone treatment depending on their individual immune response. We performed an exploratory analysis of the database from the international randomized controlled c...
Main Authors: | Rainer König, Amol Kolte, Olaf Ahlers, Marcus Oswald, Veiko Krauss, Daniela Roell, Oliver Sommerfeld, George Dimopoulos, Iraklis Tsangaris, Eleni Antoniadou, Neeraja Jaishankar, Holger Bogatsch, Markus Löffler, Markus Rödel, Marina Garcia-Moreno, Lorena Tuchscherr, Charles L. Sprung, Mervyn Singer, Frank Brunkhorst, Michael Oppert, Herwig Gerlach, Ralf A. Claus, Sina M. Coldewey, Josef Briegel, Evangelos J. Giamarellos-Bourboulis, Didier Keh, Michael Bauer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.607217/full |
Similar Items
-
Deterioration of Organ Function As a Hallmark in Sepsis: The Cellular Perspective
by: Michael Bauer, et al.
Published: (2018-06-01) -
INTRAVENOUS CLARITHROMYCIN: A VALUABLE IMMUNOMODULATOR FOR SEVERE INFECTIONS
by: Leventogiannis Konstantinos, et al.
Published: (2014-04-01) -
Intravenous clarithromycin: A valuable immunomodulator for severe infections
by: Leventogiannis Konstantinos, et al.
Published: (2014-01-01) -
Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill
by: Evdoxia Kyriazopoulou, et al.
Published: (2022-03-01) -
Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
by: Eleni Karakike, et al.
Published: (2019-01-01)